International expert consensus on the current status and future prospects of artificial intelligence in metabolic and bariatric surgery
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 18, 2025
Artificial
intelligence
(AI)
is
transforming
the
landscape
of
medicine,
including
surgical
science
and
practice.
The
evolution
AI
from
rule-based
systems
to
advanced
machine
learning
deep
algorithms
has
opened
new
avenues
for
its
application
in
metabolic
bariatric
surgery
(MBS).
potential
enhance
various
aspects
MBS,
education
training,
decision-making,
procedure
planning,
cost
time
efficiency,
optimization
techniques,
outcome
complication
prediction,
patient
education,
access
care.
However,
concerns
persist
regarding
reliability
AI-generated
decisions
associated
ethical
considerations.
This
study
aims
establish
a
consensus
on
role
MBS
using
modified
Delphi
method.
A
panel
68
leading
surgeons
35
countries
participated
this
consensus-building
process,
providing
expert
insights
into
integration
MBS.
Of
28
statements
evaluated,
at
least
70%
was
achieved
all,
with
25
reaching
first
round
remaining
three
second
round.
Experts
agreed
that
evaluation
skills
by
objective,
detailed
assessments,
enabling
personalized
feedback,
accelerating
curve.
Most
experts
also
recognized
AI's
identifying
qualified
candidates
referrals,
helping
selection,
addressing
specific
clinical
questions.
were
raised
about
overreliance
recommendations.
emphasized
need
guidelines
governing
use
inclusion
decision-making
within
consent
process.
Furthermore,
results
suggest
should
become
an
essential
component
future
training.
Advancements
AI-driven
robotics
AI-integrated
genomic
applications
identified
as
promising
developments
could
significantly
shape
Language: Английский
Acceptability of a Web-Based Health App (PortfolioDiet.app) to Translate a Nutrition Therapy for Cardiovascular Disease in High-Risk Adults: Mixed Methods Randomized Ancillary Pilot Study
JMIR Cardio,
Journal Year:
2025,
Volume and Issue:
9, P. e58124 - e58124
Published: March 28, 2025
Background
The
Portfolio
Diet
is
a
dietary
pattern
for
cardiovascular
disease
(CVD)
risk
reduction
with
5
key
categories
including
nuts
and
seeds;
plant
protein
from
specific
food
sources;
viscous
fiber
sterols;
plant-derived
monounsaturated
fatty
acid
sources.
To
enhance
implementation
of
the
Diet,
we
developed
PortfolioDiet.app,
an
automated,
web-based,
multicomponent,
patient-facing
health
app
that
was
psychological
theory.
Objective
We
aimed
to
evaluate
effect
PortfolioDiet.app
on
adherence
its
acceptability
among
adults
high
CVD
over
12
weeks.
Methods
Potential
participants
evidence
atherosclerosis
minimum
one
additional
factor
in
ongoing
trial
were
invited
participate
remote
web-based
ancillary
study
by
email.
Eligible
randomized
1:1
ratio
using
concealed
computer-generated
allocation
sequence
group
or
control
Adherence
assessed
weighed
7-day
diet
records
at
baseline
weeks
clinical
Score,
ranging
0
25.
Acceptability
evaluated
multifaceted
approach,
usability
through
System
Usability
Scale
100,
score
>70
being
considered
acceptable,
qualitative
analysis
open-ended
questions
NVivo
12.
Results
In
total,
41
main
join
email,
which
15
agreed,
14
(8
intervention
6
group)
completed
study.
At
baseline,
both
groups
mean
Score
13.2
(SD
3.7;
13.2/25,
53%)
13.7
5.8;
13.7/25,
55%)
groups,
respectively.
After
weeks,
there
tendency
increase
1.25
2.8;
1.25/25,
5%)
0.19
4.4;
0.19/25,
0.8%)
points
group,
respectively,
no
difference
between
(P=.62).
Participants
used
average
18
14)
days
per
month
rated
as
usable
(System
80.9,
SD
17.3).
Qualitative
analyses
identified
4
themes
(user
engagement,
usability,
external
factors,
added
components),
complemented
quantitative
data
obtained.
Conclusions
Although
higher
found
this
small
However,
demonstrates
high-risk
may
reinforce
dietitian
advice
follow
when
it
part
management.
Trial
Registration
ClinicalTrials.gov
NCT02481466;
https://clinicaltrials.gov/study/NCT02481466
Language: Английский
Metabolomic profiling of a cholesterol lowering plant-based diet from two randomized controlled feeding trials
European Journal of Clinical Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Language: Английский
Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling
BMC Public Health,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: May 13, 2025
Language: Английский
The Portfolio Diet and HbA1c in Adults Living with Type 2 Diabetes Mellitus: A Patient-Level Pooled Analysis of Two Randomized Dietary Trials
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(17), P. 2817 - 2817
Published: Aug. 23, 2024
The
Portfolio
Diet,
a
dietary
pattern
of
cholesterol-lowering
foods,
is
also
rich
in
low
glycemic
index
(GI)
foods.
While
strong
evidence
supports
clinically
meaningful
reductions
cholesterol,
on
the
relationship
between
Diet
and
diabetes
management
lacking.
Language: Английский